D.E. Shaw, Arrowstreet Bets Pay Off With Biogen Drug Revival

(Bloomberg) -- Biogen Inc. shareholders who stuck around despite dimming prospects for the company’s experimental Alzheimer’s therapy are being rewarded for their patience Tuesday after the shockin...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.